Aerami KOL Call: Inhaled Imatinib (AER-901) for the Treatment of Pulmonary Arterial Hypertension August 18, 2020 Continue Reading
Durham-based startup targeting diabetes raises $4.6M, looks for another $10.4M June 19, 2020 Continue Reading
555: Two Worlds, One Career | Mike Kaseta, CFO, Aerami Therapeutics December 11, 2019 Continue Reading
The Promise of More Effective Inhaled Endocrine-Focused Therapeutics October 8, 2019 Continue Reading
